These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 2670645)

  • 1. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
    Dunaif A; Segal KR; Futterweit W; Dobrjansky A
    Diabetes; 1989 Sep; 38(9):1165-74. PubMed ID: 2670645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.
    Dunaif A; Segal KR; Shelley DR; Green G; Dobrjansky A; Licholai T
    Diabetes; 1992 Oct; 41(10):1257-66. PubMed ID: 1397698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.
    Lo Dico G; Alongi G; Savatteri L; Rini GB; Mascellino MR; Di Fede G; Rizzo G
    Acta Eur Fertil; 1989; 20(5):309-13. PubMed ID: 2700062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].
    Esposito V; Federico P; Lo Iudice G; Rispoli C; Sabatino P; D'Alessandro B
    Minerva Endocrinol; 1992; 17(1):21-9. PubMed ID: 1495451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.
    Dunaif A; Graf M
    J Clin Invest; 1989 Jan; 83(1):23-9. PubMed ID: 2642919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
    Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
    Holte J; Bergh T; Berne C; Wide L; Lithell H
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2586-93. PubMed ID: 7673399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feedback inhibition of insulin secretion and insulin resistance in polycystic ovarian syndrome with and without obesity.
    Sinagra D; Scarpitta AM; Brigandì M; D'Acquisto G
    Eur Rev Med Pharmacol Sci; 1997; 1(5):167-71. PubMed ID: 9630759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women.
    Graf MJ; Richards CJ; Brown V; Meissner L; Dunaif A
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):119-31. PubMed ID: 2205423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome.
    Lewy VD; Danadian K; Witchel SF; Arslanian S
    J Pediatr; 2001 Jan; 138(1):38-44. PubMed ID: 11148510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist.
    Lanzone A; Fulghesu AM; Andreani CL; Apa R; Fortini A; Caruso A; Mancuso S
    Hum Reprod; 1990 Feb; 5(2):143-9. PubMed ID: 2108986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women.
    Dunaif A; Sorbara L; Delson R; Green G
    Diabetes; 1993 Oct; 42(10):1462-8. PubMed ID: 8375585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of oral glucose-mediated versus intravenous hyperinsulinemia on circulating androgen levels in women.
    Fox JH; Licholai T; Green G; Dunaif A
    Fertil Steril; 1993 Dec; 60(6):994-1000. PubMed ID: 8243706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].
    Calvar CE; Bengolea SV; Hermes R; Loyato M
    Medicina (B Aires); 2007; 67(1):1-7. PubMed ID: 17408014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.
    Pasquali R; Casimirri F; Venturoli S; Paradisi R; Mattioli L; Capelli M; Melchionda N; Labò G
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):110-6. PubMed ID: 6137924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome.
    Slowińska-Srzednicka J; Zgliczyński S; Wierzbicki M; Srzednicki M; Stopińska-Gluszak U; Zgliczyński W; Soszyński P; Chotkowska E; Bednarska M; Sadowski Z
    J Endocrinol Invest; 1991; 14(7):569-75. PubMed ID: 1940062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.